Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precedex for severe alcohol withdrawal syndrome
NCT01362205Phase 4Terminated
- Sponsor
- Denver Health
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in alcohol withdrawal syndrome (AWS), Alcohol withdrawal delirium (DTs), sponsored by Denver Health. Started Mar 2012; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
alcohol withdrawal syndrome (AWS)Alcohol withdrawal delirium (DTs)
Beyond the preview
Go deeper on NCT01362205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01362205.